Title |
Association between coenzyme Q10 and glucose transporter (GLUT1) deficiency
|
---|---|
Published in |
BMC Pediatrics, November 2014
|
DOI | 10.1186/s12887-014-0284-5 |
Pubmed ID | |
Authors |
Delia Yubero, Mar O’Callaghan, Raquel Montero, Aida Ormazabal, Judith Armstrong, Carmina Espinos, Maria A Rodríguez, Cristina Jou, Esperanza Castejon, Maria A Aracil, Maria V Cascajo, Angela Gavilan, Paz Briones, Cecilia Jimenez-Mallebrera, Mercedes Pineda, Plácido Navas, Rafael Artuch |
Abstract |
BackgroundIt has been demonstrated that glucose transporter (GLUT1) deficiency in a mouse model causes a diminished cerebral lipid synthesis. This deficient lipid biosynthesis could contribute to secondary CoQ deficiency. We report here, for the first time an association between GLUT1 and coenzyme Q10 deficiency in a pediatric patient.Case presentationWe report a 15 year-old girl with truncal ataxia, nystagmus, dysarthria and myoclonic epilepsy as the main clinical features. Blood lactate and alanine values were increased, and coenzyme Q10 was deficient both in muscle and fibroblasts. Coenzyme Q10 supplementation was initiated, improving ataxia and nystagmus. Since dysarthria and myoclonic epilepsy persisted, a lumbar puncture was performed at 12 years of age disclosing diminished cerebrospinal glucose concentrations. Diagnosis of GLUT1 deficiency was confirmed by the presence of a de novo heterozygous variant (c.18+2T>G) in the SLC2A1 gene. No mutations were found in coenzyme Q10 biosynthesis related genes. A ketogenic diet was initiated with an excellent clinical outcome. Functional studies in fibroblasts supported the potential pathogenicity of coenzyme Q10 deficiency in GLUT1 mutant cells when compared with controls.ConclusionOur results suggest that coenzyme Q10 deficiency might be a new factor in the pathogenesis of G1D, although this deficiency needs to be confirmed in a larger group of G1D patients as well as in animal models. Although ketogenic diet seems to correct the clinical consequences of CoQ deficiency, adjuvant treatment with CoQ could be trialled in this condition if our findings are confirmed in further G1D patients. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Scientists | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 2% |
Canada | 1 | 2% |
Unknown | 54 | 96% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 12 | 21% |
Student > Bachelor | 10 | 18% |
Student > Ph. D. Student | 5 | 9% |
Student > Master | 5 | 9% |
Student > Postgraduate | 4 | 7% |
Other | 12 | 21% |
Unknown | 8 | 14% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 12 | 21% |
Agricultural and Biological Sciences | 11 | 20% |
Biochemistry, Genetics and Molecular Biology | 10 | 18% |
Nursing and Health Professions | 4 | 7% |
Neuroscience | 3 | 5% |
Other | 4 | 7% |
Unknown | 12 | 21% |